New Delhi: India has received approval to use the first vaccine on New Year amid Corona epidemic. The emergency committee meeting considered giving emergency approval to Kovishield, the Corona vaccine of Oxford AstraZeneca, after which the emergency use of the Covishield vaccine being made by the Serum Institute was approved. However, according to the government's top sources, Kovishield of Serum Institute of India (SII) has received recommendation from the panel for approval. But the final decision on this is yet to be taken by DCGI.
According to the information received from inside the meeting, Pfizer, Bharat Biotech and Serum Institute all three had to present their presentations one after the other. Zydus Cadila has also joined the meeting. The presentation of the Serum Institute has been done, with which the emergency use of Kovishield has been approved. The presentation of Bharat Biotech is now going on in the expert committee meeting. Bharat Biotech Vaccine Cocaine is currently being discussed. Finally, Pfizer's presentation will take place.
No comments:
Post a Comment